MX2010009575A - Derivados de pirazinonas como estimulantes de la secrecion de insulina, metodos para obtenerlos y su uso en el tratamiento de la diabetes. - Google Patents
Derivados de pirazinonas como estimulantes de la secrecion de insulina, metodos para obtenerlos y su uso en el tratamiento de la diabetes.Info
- Publication number
- MX2010009575A MX2010009575A MX2010009575A MX2010009575A MX2010009575A MX 2010009575 A MX2010009575 A MX 2010009575A MX 2010009575 A MX2010009575 A MX 2010009575A MX 2010009575 A MX2010009575 A MX 2010009575A MX 2010009575 A MX2010009575 A MX 2010009575A
- Authority
- MX
- Mexico
- Prior art keywords
- diabetes
- treatment
- insulin secretion
- obtaining
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Derivados de pirazinona de fórmula (I), donde n, R1, R2, R3 y R4 tienen los valores que se definen en la reivindicación 1, como estimulantes de la secreción de insulina. La invención también se relaciona con la preparación y el uso de estos derivados de pirazinona para la profilaxis y/o el tratamiento de la diabetes y patologías asociadas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08004193 | 2008-03-05 | ||
PCT/EP2009/000213 WO2009109259A1 (en) | 2008-03-05 | 2009-01-15 | Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010009575A true MX2010009575A (es) | 2010-09-24 |
Family
ID=40565210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010009575A MX2010009575A (es) | 2008-03-05 | 2009-01-15 | Derivados de pirazinonas como estimulantes de la secrecion de insulina, metodos para obtenerlos y su uso en el tratamiento de la diabetes. |
Country Status (18)
Country | Link |
---|---|
US (2) | US8637522B2 (es) |
EP (1) | EP2250156B1 (es) |
JP (1) | JP5530370B2 (es) |
KR (1) | KR101637381B1 (es) |
CN (1) | CN101945858B (es) |
AR (1) | AR070798A1 (es) |
AU (1) | AU2009221328B2 (es) |
BR (1) | BRPI0908544A2 (es) |
CA (1) | CA2717753C (es) |
DK (1) | DK2250156T3 (es) |
EA (1) | EA021325B1 (es) |
ES (1) | ES2543598T3 (es) |
HU (1) | HUE025132T2 (es) |
IL (1) | IL207719A (es) |
MX (1) | MX2010009575A (es) |
PT (1) | PT2250156E (es) |
WO (1) | WO2009109259A1 (es) |
ZA (1) | ZA201007060B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
CN102260268B (zh) * | 2011-06-19 | 2013-04-03 | 漆又毛 | 苄硫基乙酰胺基乙酰吡嗪***衍生物及制备与应用 |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH609989A5 (en) | 1974-06-21 | 1979-03-30 | Hoffmann La Roche | Process for the preparation of acyl derivatives |
EP0008864A1 (en) * | 1978-08-15 | 1980-03-19 | FISONS plc | Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them |
EP0927171B1 (en) | 1996-09-16 | 2002-02-20 | Du Pont Pharmaceuticals Company | Pyrazinones and triazinones and their derivatives thereof |
ES2412007T3 (es) * | 2005-12-21 | 2013-07-09 | Janssen Pharmaceutica, N.V. | Derivados de pirazinona sustituida novedosos para uso en enfermedades mediadas por MCH-1 |
US20090011994A1 (en) | 2007-07-06 | 2009-01-08 | Bristol-Myers Squibb Company | Non-basic melanin concentrating hormone receptor-1 antagonists and methods |
-
2009
- 2009-01-15 JP JP2010549025A patent/JP5530370B2/ja active Active
- 2009-01-15 PT PT97182042T patent/PT2250156E/pt unknown
- 2009-01-15 EA EA201001408A patent/EA021325B1/ru not_active IP Right Cessation
- 2009-01-15 CN CN200980105290.3A patent/CN101945858B/zh active Active
- 2009-01-15 EP EP20090718204 patent/EP2250156B1/en active Active
- 2009-01-15 WO PCT/EP2009/000213 patent/WO2009109259A1/en active Application Filing
- 2009-01-15 ES ES09718204.2T patent/ES2543598T3/es active Active
- 2009-01-15 US US12/920,932 patent/US8637522B2/en active Active
- 2009-01-15 AU AU2009221328A patent/AU2009221328B2/en active Active
- 2009-01-15 MX MX2010009575A patent/MX2010009575A/es active IP Right Grant
- 2009-01-15 BR BRPI0908544A patent/BRPI0908544A2/pt not_active Application Discontinuation
- 2009-01-15 CA CA2717753A patent/CA2717753C/en active Active
- 2009-01-15 KR KR1020107022241A patent/KR101637381B1/ko active IP Right Grant
- 2009-01-15 DK DK09718204.2T patent/DK2250156T3/en active
- 2009-01-15 HU HUE09718204A patent/HUE025132T2/en unknown
- 2009-03-05 AR ARP090100782A patent/AR070798A1/es unknown
-
2010
- 2010-08-19 IL IL207719A patent/IL207719A/en active IP Right Grant
- 2010-10-04 ZA ZA2010/07060A patent/ZA201007060B/en unknown
-
2013
- 2013-12-17 US US14/109,225 patent/US9102632B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
BRPI0908544A2 (pt) | 2015-09-29 |
WO2009109259A1 (en) | 2009-09-11 |
PT2250156E (pt) | 2015-09-09 |
HUE025132T2 (en) | 2016-01-28 |
CA2717753C (en) | 2016-09-13 |
US8637522B2 (en) | 2014-01-28 |
IL207719A0 (en) | 2010-12-30 |
US20110015210A1 (en) | 2011-01-20 |
EP2250156B1 (en) | 2015-05-06 |
ES2543598T3 (es) | 2015-08-20 |
AU2009221328B2 (en) | 2014-02-27 |
KR101637381B1 (ko) | 2016-07-07 |
CA2717753A1 (en) | 2009-09-11 |
ZA201007060B (en) | 2011-06-29 |
AU2009221328A1 (en) | 2009-09-11 |
JP5530370B2 (ja) | 2014-06-25 |
US9102632B2 (en) | 2015-08-11 |
EA021325B1 (ru) | 2015-05-29 |
IL207719A (en) | 2015-05-31 |
US20140100235A1 (en) | 2014-04-10 |
CN101945858A (zh) | 2011-01-12 |
DK2250156T3 (en) | 2015-08-03 |
KR20100123900A (ko) | 2010-11-25 |
CN101945858B (zh) | 2014-05-21 |
EA201001408A1 (ru) | 2011-06-30 |
JP2011513344A (ja) | 2011-04-28 |
EP2250156A1 (en) | 2010-11-17 |
AR070798A1 (es) | 2010-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010009576A (es) | Derivados de quinoxalinona como estimulantes de la secrecion de insulina, metodos para obtenerlos y su uso en el tratamiento de la diabetes. | |
MX2010009575A (es) | Derivados de pirazinonas como estimulantes de la secrecion de insulina, metodos para obtenerlos y su uso en el tratamiento de la diabetes. | |
TN2012000249A1 (en) | Pyrazine derivatives and their use in the treatment of neurological disorders | |
IN2012DN01233A (es) | ||
UA98961C2 (uk) | Похідні піразинону та їх застосування у лікуванні легеневих захворювань | |
MX2012004525A (es) | Compuestos. | |
MX2012001070A (es) | Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurologicos. | |
MX2009009416A (es) | Derivados de bencimidazol y sus metodos de uso. | |
IL185808A0 (en) | Amide-substituted 8-n-benzimidazoles, metohd for the production thereof, and use of the same as medicaments | |
JO2682B1 (en) | Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof | |
MX2010009922A (es) | Activadores de piridazinona glucocinasa. | |
UA102858C2 (ru) | Производные пиридино-пиридинонов, способ их получения и применения в терапии | |
TW200616985A (en) | Salicylthiazoles substituted by diphenylamine or diphenylamine derivatives, process for their preparation and their use | |
MX2012007582A (es) | Compuestos de 4-fenoxi-nicotinamida o 4-fenoxi-pirimidina-5-carbox amida. | |
MX2010009577A (es) | Derivados de piridopirazinona que estimulan la secrecion de insulina, metodos para obtenerlos y su uso en el tratamiento de la diabetes. | |
EA201201623A1 (ru) | Лечение диабета 2 типа | |
MX2011008360A (es) | Derivados de piridazinona sustituida con heteroarilo. | |
MX2013002208A (es) | Derivados de sulfonilpiperazina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes. | |
UA103191C2 (ru) | Производные арилпиразинона как стимуляторы секреции инсулина, способ их получения (варианты) и их применение для лечения диабета | |
MX2010009837A (es) | Tiazolil-dihidro-indazoles. | |
TN2011000531A1 (en) | 5- alkynyl - pyridines | |
MX2010009999A (es) | Derivados de amidas del acido 3-trifluorometil-pirazina-2-carboxil ico como agentes para aumentar el colesterol de lipoproteinas de alta densidad. | |
PL1904511T3 (pl) | Homogemcytabiny | |
TN2011000049A1 (en) | 5-alkynyl-pyrimidines | |
MA33958B1 (fr) | Derives de pyrazine et leur utilisation dans le traitement de troubles neurologiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |